Laurel Wealth Advisors, Inc. Amgen Inc Transaction History

Laurel Wealth Advisors, Inc.

$1.01 Billion
Q4 2022

A detailed history of Laurel Wealth Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 5,995 shares of AMGN stock, worth $1.59 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

5,995

Previous 5,654 6.03%

Holding current value

$1.59 Million

Previous $1.28 Million 23.45%

% of portfolio

0.16%

Previous 0.14%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $78,099 - $99,234	341 Added 6.03%	5,995 $1.57 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $4,264 - $4,809	19 Added 0.34%	5,654 $1.28 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $159,420 - $177,407	-691 Reduced 10.92%	5,635 $1.37 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $160,505 - $177,561	-732 Reduced 10.37%	6,326 $1.53 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $382,645 - $437,902	1,924 Added 37.48%	7,058 $1.59 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $85,544 - $100,226	-403 Reduced 7.28%	5,134 $1.09 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $52,321 - $58,047	-224 Reduced 3.89%	5,537 $1.35 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $11,095 - $12,930	-50 Reduced 0.86%	5,761 $1.43 Million
Q4 2020 Mar 03, 2021	SELL	$216.38 - $257.67 $46,738 - $55,656	-216 Reduced 3.58%	5,811 $1.34 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $11,967 - $13,308	-51 Reduced 0.84%	6,027 $1.53 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $15,429 - $18,933	78 Added 1.3%	6,078 $1.43 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $27,700 - $36,738	-152 Reduced 2.47%	6,000 $1.22 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $92,145 - $118,438	-487 Reduced 7.34%	6,152 $1.48 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $119,091 - $142,696	684 Added 11.49%	6,639 $1.29 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $8,001 - $9,379	48 Added 0.81%	5,955 $1.1 Million
Q1 2019 May 16, 2019	BUY	$180.87 - $203.88 $107,617 - $121,308	595 Added 11.2%	5,907 $1.12 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $114,889 - $134,113	-644 Reduced 10.81%	5,312 $1.03 Million
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $2,779 - $3,133	15 Added 0.25%	5,956 $1.23 Million
Q2 2018 Aug 20, 2018	BUY	$166.05 - $186.51 $57,951 - $65,091	349 Added 6.24%	5,941 $1.1 Million
Q1 2018 May 16, 2018	SELL	$169.43 - $198.0 $9,318 - $10,890	-55 Reduced 0.97%	5,592 $953,000
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $150,560 - $168,222	892 Added 18.76%	5,647 $982,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $55,372 - $63,221	331 Added 7.48%	4,755 $886,000
Q2 2017 Aug 15, 2017	BUY	N/A	4,424	4,424 $762,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.

Account

Laurel Wealth Advisors, Inc. Amgen Inc Transaction History